12,552 findings · published 2017+
- MolecularStrong
The oleogel-in-oleogel system reduces in vitro digestibility by 17%–26% compared to control oleogels and up to 33% compared to single-component oleogels.
This system may help in reducing caloric intake from fats, aiding in obesity management.
Supports 2025New - MolecularStrong
The type of outer oleogel affects the digestibility of the oleogel-in-oleogel system.
Choosing the right outer oleogel could optimize the digestibility of fat substitutes.
Supports 2025New - MolecularStrong
Inhibiting the Group-specific component (GC) gene may provide a novel therapeutic target for treating metabolic diseases.
Practitioners may consider exploring GC inhibition as a treatment option for metabolic diseases.
Supports 2026New - Metabolic adaptationStrong
GC ablation in mice fed a high fat diet protects against obesity and type 2 diabetes.
This suggests that targeting GC could be beneficial in preventing obesity in high-fat diet scenarios.
Supports 2026New - Energy balanceStrong
Inhibiting GC does not lead to reductions in food intake or lean mass.
This indicates that GC inhibition could be a safer alternative to current treatments that suppress appetite.
Supports 2026New - CellularStrong
GLP-1 RA-induced gastroparesis can increase the risk of aspiration during ophthalmic surgery.
Surgeons should be aware of the aspiration risk in patients using GLP-1 RAs.
Supports 2026New - NeuralStrong
Preoperative screening and interdisciplinary coordination are important for patients using GLP-1 RAs undergoing ophthalmic surgery.
Healthcare teams should ensure thorough preoperative assessments for these patients.
Supports 2026New - Metabolic adaptationStrong
Adjustment for covariates differing between trial type and associated with BW reduction nullified the association between T2D status and weight loss (p = 0.93).
This suggests that addressing demographic and comorbid factors may improve weight loss outcomes in T2D patients.
Refutes 2026New - CellularStrong
GLP-1R agonists can improve cardiac contractility in human hearts.
Practitioners may consider GLP-1R agonists as a potential treatment to enhance heart contractility.
Supports 2026New - MolecularStrong
GLP-1R agonists raise cAMP levels in cardiac cells.
Understanding the role of cAMP may help in developing therapies targeting cardiac function.
Supports 2026New - CellularStrong
Epicardial adipose tissue may contribute to arrhythmogenesis through pro-inflammatory and pro-fibrotic effects.
Addressing epicardial adipose tissue may be important in managing arrhythmias in obese patients.
Supports 2026New - HormonalStrong
Current evidence does not support a single dominant mechanism for the efficacy of GLP-1 receptor agonists.
Practitioners should consider multiple factors influencing the effectiveness of GLP-1 receptor agonists.
Qualifies 2026New - HormonalStrong
The DRL model decreased the time-to-therapeutic-dose by 20% in simulations.
Using a DRL agent can expedite achieving therapeutic doses for patients.
Supports 2026New - Energy balanceStrong
No effects of protein supplementation were observed on muscle volume, muscle strength, or return to sport (RTS).
Protein supplementation may not be beneficial during early rehabilitation for muscle strain injuries.
Refutes 2025New - CellularStrong
Dietary protein intake did not affect daily myofibrillar protein synthesis rates during immobilization.
Practitioners should note that increasing dietary protein may not mitigate muscle loss during short-term disuse.
Refutes 2023 - Energy balanceStrong
Further studies with larger samples and long-term follow-up are needed.
Encourage ongoing research to validate and refine strength training protocols for this population.
Qualifies 2025New - Metabolic adaptationStrong
No significant differences in metabolic flexibility were observed between the RE+CON and RE+PRO groups.
Combining resistance exercise with either a control or high protein diet does not significantly alter metabolic flexibility outcomes.
Refutes 2026New - MolecularStrong
PPARγ inhibition reverses ALOXE3-mediated insulin sensitization.
Inhibiting PPARγ may counteract the benefits of ALOXE3 in insulin sensitivity.
Supports 2018 - Energy balanceStrong
Knowledge about nutrition and food components was not affected by the nutrition consultations.
Practitioners should note that while eating behavior improves, nutrition knowledge may not change significantly.
Refutes 2021 - Energy balanceStrong
The mortality of German T2D patients enrolled in the Disease Management Program (DMP) is 2.4 times higher than that of the general population.
Practitioners should consider the elevated mortality risk for T2D patients in the DMP when planning care.
Supports 2020 - CellularStrong
Gastric bypass surgery performed without division of the mesentery significantly reduces postoperative complications such as leakage and ulceration/stenosis.
Surgeons should consider the intact mesentery technique to minimize complications.
Supports 2017 - Metabolic adaptationStrong
Polypharmacy is more common in women with diabetes than in men with diabetes.
Healthcare providers should be aware of the higher likelihood of polypharmacy in female diabetes patients.
Supports 2021 - CellularStrong
Adipositas ist eine multifaktorielle Erkrankung mit global steigender Prävalenz.
Practitioners should recognize the multifactorial nature of obesity when addressing it in patients.
Supports 2025New - Energy balanceStrong
Obesity rates have climbed to 58% of the adult population across OECD countries.
Health professionals should be aware of the high prevalence of obesity in OECD countries.
Supports 2019